- PMLiVE

How can virtual pharma companies de-risk new product launches?

The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market

- PMLiVE

Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?

Providers are looking at digital solutions to transform this area of healthcare

- PMLiVE

PMEA 2020: continuing to recognise excellence in improving patient outcomes

The 20th annual PMEAs took place virtually this year due to COVID-19

- PMLiVE

Novartis and smartpatient launch app experience for wet AMD patients

Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65

- PMLiVE

The new world of association congresses

It’s time we reimagined the rules of engagement

- PMLiVE

Bayer’s drop of the future

Digital health isn’t always about digital

- PMLiVE

AI: the smart money is on the smart thinking

Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials

- PMLiVE

Key emerging trends in digital health

Improving healthcare for patients and helping doctors be more efficient

- PMLiVE

Current and future trends for developing digital medical communications

Evolving digital trends and user needs

- PMLiVE

Policy and public health: ML and AI in healthcare

What are the hurdles for machine learning and artificial intelligence in pharma?

- PMLiVE

WHO partners with WhatsApp to provide accurate COVID-19 information

Social media platform will provide users with facts around virus

- PMLiVE

BMS partners with Voluntis to co-develop oncology digital therapeutics

Aims to create a mobile app to help patients self-manage their symptoms

Digital divergence

Combining digital and pharma is proving less easy than previously thought

- PMLiVE

The digital shift in pharma marketing

Indegene’s surveys in 2016 and 2019 show a spike in digital spend

- PMLiVE

Google’s DeepMind AI outperforms doctors on breast cancer screening

System reduced false positive and false negative decisions